Chiltern has entered an agreement to acquire Theorem Clinical Research. The combined company will operate under the name Chiltern and will have global reach — most notably in China and Japan — as well as new service offerings for medical devices and diagnostics, clinical analytics and clinical supplies. Financial terms were not disclosed. The transaction, subject to customary regulatory and closing conditions, is expected to close in the next few weeks.   Chiltern, a UK-based CRO, has three sp...